Treatment for Psychological and Drug Abuse Problems

NCT01140334 | Completed

• 1 other identifier: 1RC1DA028154-01
• Study Type: interventional
• Target: 158
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of the study is to evaluate methods to help people in substance abuse treatment receive better psychiatric care. Patients enrolled in the study will be offered three months of standard psychiatric treatment, which consists of weekly individual counseling and group counseling, as well as regular appointments with a psychiatrist. Patients will be randomly assigned to standard psychiatric care or standard psychiatric care plus voucher incentives. These incentives can be earned by successfully attending all scheduled psychiatric appointments each week. The investigators expect that patients in the voucher condition will attend more psychiatric sessions, which will lead to greater reductions in psychiatric distress.

Conditions

Substance Use Disorders

Keywords

Psychiatric adherence; Voucher incentives; Methadone treatment

Outcome Measures

Primary Outcomes (2)

• Psychiatric Treatment Adherence

  Patient adherence to all scheduled psychiatric sessions (i.e. individual, group, psychiatrist) will be measured weekly for 12 weeks.

  Weekly for 12 weeks

• Level of Psychiatric Distress

  Patients will complete the Addiction Severity Index (ASI) and the SCL-90 every 4-weeks, for 12-weeks, to measure their current levels of psychiatric distress.

  Every 4-weeks for 12 weeks

Secondary Outcomes (3)

• Psychiatric Medication Adherence

  Every 4-weeks

• Substance Use

  Weekly for 12-weeks

• Treatment Retention

  Weekly for 12-weeks

Study Arms (2)

Reinforced On-Site Integrated Care (ROIC)

EXPERIMENTAL

Patients assigned to this condition will be treated at ATS for psychological problems. They will be scheduled to participate in individual therapy sessions with a psychiatrist and with their substance abuse counselor. They will also be referred to attend group therapy one time per week. In addition, they will be able to earn a voucher incentive for each week of psychiatric compliance.

Behavioral: Voucher Reinforcement

Standard On-Site Integrated Care (SOIC).

ACTIVE COMPARATOR

Patients assigned to this condition will be treated at ATS for psychological problems. They will be scheduled to participate in individual therapy sessions with a psychiatrist and with their substance abuse counselor. They will also be referred to attend group therapy one time per week.

Behavioral: Standard Control

Interventions

Voucher Reinforcement BEHAVIORAL

Patients in this condition will be able to earn a voucher for each week that they have attended all scheduled psychiatric sessions. These sessions may include individual therapy appointments, group therapy appointments, or psychiatrist appointments. Each voucher will be worth $25, and can be exchanged for goods and services that will be purchased by a research assistant. The maximum amount of voucher earnings over the study is $300.

Reinforced On-Site Integrated Care (ROIC)

Standard Control BEHAVIORAL

Patients assigned to this condition will be treated at ATS for psychological problems. They will be scheduled to participate in individual therapy sessions with a psychiatrist and with their substance abuse counselor. They will also be referred to attend group therapy one time per week. No voucher incentive will be offered in this condition.

Standard On-Site Integrated Care (SOIC).

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• At least 18 years of age
• Voluntarily seeking psychiatric treatment
• Meets DSM-IV criteria for opiate dependence
• Meets FDA/CSAT guidelines for methadone maintenance
• Meets DSM-IV criteria for at least one current psychiatric disorder

You may not qualify if:

• Pregnancy
• Onset or acute exacerbation of a medical illness requiring immediate and intense care
• An organic mental disorder (e.g., delirium, dementia)
• Current participation in psychiatric care
• Mandatory psychiatric treatment

Sponsors & Collaborators

• Johns Hopkins University: lead
• National Institute on Drug Abuse (NIDA): collaborator

Study Sites (1)

Addiction Treatment Services

Baltimore, Maryland, 21224, United States

Location

Related Publications (1)

• Kidorf M, Brooner RK, Gandotra N, Antoine D, King VL, Peirce J, Ghazarian S. Reinforcing integrated psychiatric service attendance in an opioid-agonist program: a randomized and controlled trial. Drug Alcohol Depend. 2013 Nov 1;133(1):30-6. doi: 10.1016/j.drugalcdep.2013.06.005. Epub 2013 Jul 15.

  PMID: 23866988 RESULT

MeSH Terms

Conditions

Substance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced Disorders; Mental Disorders

Study Officials

• Michael Kidorf, Ph.D.

  Johns Hopkins University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor

Study Record Dates

• First Submitted: June 3, 2010
• First Posted: June 9, 2010
• Study Start: December 1, 2009
• Primary Completion: August 1, 2012
• Study Completion: August 1, 2012
• Last Updated: September 20, 2013

Record last verified: 2013-09

Locations

US (1)